Roberto H Nussenzveig Selected Research

Steroid Synthesis Inhibitors

7/2022

Survival of Patients with Metastatic Prostate Cancer After Disease Progression on an Androgen Receptor Axis-Targeted Therapy Given in the Metastatic Castration-Sensitive Versus Metastatic Castration-Resistant Prostate Cancer Setting.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roberto H Nussenzveig Research Topics

Disease

6	Prostatic Neoplasms (Prostate Cancer) 07/2022 - 01/2018
4	Neoplasms (Cancer) 07/2022 - 01/2018
3	Disease Progression 07/2022 - 01/2018
3	Polycythemia Vera 12/2012 - 06/2008
2	Hereditary Elliptocytosis 01/2014 - 12/2013
2	Jaundice (Icterus) 01/2014 - 01/2014
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2019
1	Carcinoma (Carcinomatosis) 01/2018
1	Neonatal Jaundice 01/2014
1	Hereditary Spherocytosis 01/2014
1	Hereditary Pyropoikilocytosis 12/2013
1	Hemolytic Anemia 12/2013
1	Thalassemia 09/2013
1	Kernicterus 08/2013
1	Methemoglobinemia 11/2006

Drug/Important Bio-Agent (IBA)

3	Androgen Receptors (Androgen Receptor)IBA 07/2022 - 01/2019
3	Cell-Free Nucleic AcidsIBA 01/2021 - 01/2018
3	Circulating Tumor DNAIBA 01/2020 - 01/2018
3	SpectrinIBA 01/2014 - 12/2013
2	Abiraterone AcetateIBA 01/2019 - 01/2018
2	Prednisone (Sone)FDA LinkGeneric 01/2019 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2018
1	Steroid Synthesis InhibitorsIBA 07/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	SaltsIBA 01/2019
1	Neurofibromin 1 (Neurofibromin)IBA 01/2019
1	CateninsIBA 01/2019
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	AndrogensIBA 01/2018
1	Ketoconazole (Nizoral)FDA LinkGeneric 01/2018
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 01/2018
1	Pyruvate KinaseIBA 01/2014
1	Hemoglobins (Hemoglobin)IBA 01/2014
1	Messenger RNA (mRNA)IBA 12/2013
1	GlobinsIBA 09/2013
1	BilirubinIBA 08/2013
1	ParaffinIBA 12/2012
1	Imatinib Mesylate (Gleevec)FDA Link 07/2009
1	tofacitinibIBA 06/2008
1	Janus Kinase 2IBA 06/2008
1	Phosphotransferases (Kinase)IBA 06/2008
1	Oxidoreductases (Dehydrogenase)IBA 11/2006
1	Cytochromes b5 (Cytochrome b5)IBA 11/2006

Therapy/Procedure

5	Therapeutics 07/2022 - 07/2009
5	Castration 07/2022 - 01/2018